Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (CE) alone or in combination with nivolumab as frontline therapy for extensive stage small cell lung cancer (ESSCLC): ECOG-ACRIN EA5161

Category Primary study
ConferenceASCO Annual Meeting I. Journal of Clinical Oncology
Year 2020
This article has no abstract
Epistemonikos ID: ae1915822c9b9f622fcd92f03ae1c51ec269bdda
First added on: Dec 20, 2022